Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Van Den Berg, Jolice P ^a   Westerbeek, Elisabeth A M ^a   Smits, Gaby P ^b   Van Der Klis, Fiona R M ^b   Berbers, Guy A M ^b   Van Elburg, Ruurd M ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c Nutricia Nederland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MATERNAL ANTIBODY; MEASLES ANTIBODY; MUMPS ANTIBODY; RUBELLA ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ACTIVE TRANSPORT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; MATERNAL SERUM; NEWBORN; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PREDICTOR VARIABLE; PREMATURITY; SEROPREVALENCE; BLOOD; CHICKENPOX; EPIDEMIOLOGY; IMMUNOLOGY; MEASLES; MUMPS; PLACENTA; PREGNANCY; RUBELLA VIRUS;

ADULT; ANTIBODIES, VIRAL; CHICKENPOX; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT, NEWBORN; INFANT, PREMATURE; MEASLES; MUMPS; PLACENTA; PREGNANCY; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84899647805     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094714     Document Type: Article

References (53)

1. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H (1996) Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 36: 248-255.
2. Leineweber B, Grote V, Schaad UB, Heininger U (2004) Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J 23: 361-363.
3. Linder N, Tallen-Gozani E, German B, Duvdevani P, Ferber A, et al. (2004) Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status. Vaccine 22: 1509-1514.
4. Linder N, Waintraub I, Smetana Z, Barzilai A, Lubin D, et al. (2000) Placental transfer and decay of varicella-zoster virus antibodies in preterm infants. J Pediatr 137: 85-89.
5. van den Berg JP, Westerbeek EA, van der Klis FR, Berbers GA, van Elburg RM (2011) Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev 87: 67-72.
6. van den Berg JP, Westerbeek EA, Berbers GA, van Gageldonk PG, van der Klis FR, et al. (2010) Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J 29: 801-805.
7. Jauniaux E, Jurkovic D, Gulbis B, Liesnard C, Lees C, et al. (1995) Maternofetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. Hum Reprod 10: 3297-3300.
8. Simister NE (2003) Placental transport of immunoglobulin G. Vaccine 21: 3365-3369.
9. Malek A (2003) Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. Vaccine 21: 3362-3364.
10. van Der Zwet WC, Vandenbroucke-Grauls CM, van Elburg RM, Cranendonk A, Zaaijer HL (2002) Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics 109: 79-85.
11. de Voer RM, van der Klis FR, Nooitgedagt JE, Versteegh FG, van Huisseling JC, et al. (2009) Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis. Clin Infect Dis 49: 58-64.
12. Pitcher-Wilmott RW, Hindocha P, Wood CB (1980) The placental transfer of IgG subclasses in human pregnancy. Clin Exp Immunol 41: 303-308.
13. Blume S, Tump J (2010) Evidence and policymaking: The introduction of MMR vaccine in the Netherlands. Soc Sci Med 71: 1049-1055.
14. Zanetta RA, Amaku M, Azevedo RS, Zanetta DM, Burattini MN, et al. (2001) Optimal age for vaccination against measles in the State of Sao Paulo, Brazil, taking into account the mother's serostatus. Vaccine 20: 226-234.
15. van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA (1999) Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine 18: 931-940.
16. van den Hof S, Conyn-van Spaendonck MA, van Steenbergen JE (2002) Measles epidemic in the Netherlands, 1999-2000. J Infect Dis 186: 1483-1486.
17. Hartter HK, Oyedele OI, Dietz K, Kreis S, Hoffman JP, et al. (2000) Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J 19: 635-641.
18. Waaijenborg S, Hahne SJ, Mollema L, Smits GP, Berbers GA, et al. (2013) Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage. J Infect Dis 208: 10-16.
19. Mollema L, Hahné S (2013) Measle surveillance report [Mazelensurveillanceoverzicht]. RIVM.
20. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS (2013) Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62: 1-34.
21. Westerbeek EA, van Elburg RM, van den Berg A, van den Berg J, Twisk JW, et al. (2008) Design of a randomised controlled trial on immune effects of acidic and neutral oligosaccharides in the nutrition of preterm infants: carrot study. BMC Pediatr 8: 46.
22. Smits GP, van Gageldonk PG, Schouls LM, van der Klis FR, Berbers GA (2012) Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin Vaccine Immunol 19: 396-400.
23. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, et al. (1990) Measles antibody: reevaluation of protective titers. J Infect Dis 162: 1036-1042.
24. Christenson B, Bottiger M (1990) Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus. Biologicals 18: 207-211.
25. Skendzel LP (1996) Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 106: 170-174.
26. Hahne S, te Wierik MJ, Mollema L, van Velzen E, de Coster E, et al. (2010) Measles outbreak, the Netherlands, 2008. Emerg Infect Dis 16: 567-569.
27. Swart E, Knol M (2013) Measles and rubella surveillance report [Mazelen en rubella surveillance overzicht].
28. Leuridan E, Sabbe M, Van Damme P (2012) Measles outbreak in Europe: susceptibility of infants too young to be immunized. Vaccine 30: 5905-5913.
29. Muscat M, Bang H, Wohlfahrt J, Glismann S, Molbak K (2009) Measles in Europe: an epidemiological assessment. Lancet 373: 383-389.
30. Strebel P PM, Dayan G, Halsey N. (2008) Measles vaccines. In: O. W. Plotkin S, Offit P, editor editors. Vaccines.Philadelphia: Saunders. pp. 354.
31. World Health Organization (2005) Eliminating measles and rubella and prevention congenital rubella infection. WHO European region strategic plan 2005-2010. WHO.
32. European Centre for Disease Prevention and Control (2013) Measles and rubella monitoring. Stockholm: ECDC.
33. European Centre for Disease Prevention and Control (2010) Annual Epidemiological Report on Communicable Diseases in Europe 2010. Stockholm: ECDC.
34. Greenland K, Whelan J, Fanoy E, Borgert M, Hulshof K, et al. (2012) Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine 30: 4676-4680.
35. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, et al. (2012) Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 15.
36. Nardone A, de Ory F, Carton M, Cohen D, van Damme P, et al. (2007) The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25: 7866-7872.
37. van Lier A, Smits G, Mollema L, Waaijenborg S, Berbers G, et al. (2013) Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine 31: 5127-5133.
38. Janaszek W, Slusarczyk J (2003) Immunity against measles in populations of women and infants in Poland. Vaccine 21: 2948-2953.
39. Kacica MA, Venezia RA, Miller J, Hughes PA, Lepow ML (1995) Measles antibodies in women and infants in the vaccine era. J Med Virol 45: 227-229.
40. Ohsaki M, Tsutsumi H, Takeuchi R, Kuniya Y, Chiba S (1999) Reduced passive measles immunity in infants of mothers who have not been exposed to measles outbreaks. Scandinavian journal of infectious diseases 31: 17-19.
41. Pabst HF, Spady DW, Marusyk RG, Carson MM, Chui LW, et al. (1992) Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J 11: 525-529.
42. Maldonado YA, Lawrence EC, DeHovitz R, Hartzell H, Albrecht P (1995) Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 96: 447-450.
43. de Haas R, van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA (1999) Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination. Epidemiol Infect 123: 263-270.
44. Borras E, Urbiztondo L, Costa J, Batalla J, Torner N, et al. (2012) Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Epidemiol Infect 140: 1599-1606.
45. Siegrist CA (2003) Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 21: 3406-3412.
46. Klinge J, Lugauer S, Korn K, Heininger U, Stehr K (2000) Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age. Vaccine 18: 3134-3140.
47. Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, et al. (2004) Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. J Infect Dis 189 Suppl 1: S116-122.
48. Arciuolo RJM, Tamara R. Brantley, MPH, Mekete M. Asfaw, Rachel R. . Jablonski, Jie Fu, PhD, Francesca R. . Giancotti, PhD, Jennifer B. . Rosen, MD, (2013) Notes from the Field: Measles Outbreak Among Members of a Religious Community - Brooklyn, New York, March-June 2013. Morbidity and Mortality Weekly Report.
49. National Institute of Public Health and the Environment (2011) LCI guideline Measles (morbilli) [LCI richtlijn Mazelen (morbilli)].
50. Ichikawa T, Tsuji A, Fujino M, Kusano R, Sugiyama R, et al. (2013) Effect of early measles vaccination (AIK-C strain) for preterm infants. Pediatr Int 55: 163-168.
51. McLean HQ PFA, Temte JL, Wallace GS (2013) Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62: 1-34.
52. Practice Committee of American Society for Reproductive Medicine (2008) Vaccination guidelines for female infertility patients. Fertil Steril 90: S169-171.
53. Pinsky NA, Loepfe TR, Jacobson RM, Vierkant RA, Poland GA (2003) Comparison of fingerstick versus venipuncture for antibody testing of measles and rubella. Scand J Infect Dis 35: 107-109.